MATRIX METALLOPROTEINASE-7 (MATRILYSIN) FROM HUMAN RECTAL-CARCINOMA CELLS - ACTIVATION OF THE PRECURSOR, INTERACTION WITH OTHER MATRIX METALLOPROTEINASES AND ENZYMATIC-PROPERTIES
K. Imai et al., MATRIX METALLOPROTEINASE-7 (MATRILYSIN) FROM HUMAN RECTAL-CARCINOMA CELLS - ACTIVATION OF THE PRECURSOR, INTERACTION WITH OTHER MATRIX METALLOPROTEINASES AND ENZYMATIC-PROPERTIES, The Journal of biological chemistry, 270(12), 1995, pp. 6691-6697
Matrix metalloproteinase 7 (MMP-7) has been purified as an inactive zy
mogen of M(r), 28,000 (proMMP-7) from the culture medium of CaR-1 huma
n rectal carcinoma cells. The NH2-terminal sequence of proMMP-7 is Lys
-Pro-Lys-Pro-Gln-Glu, which is identical to that of matrilysin. The zy
mogen is activated by 4-aminophenylmercuric acetate (APMA), yielding a
n intermediate form of M(r) 21,000 and an active species of M(r) 19,00
0 which shows the new NH2-terminal sequence of Tyr(78)-Ser-Leu-Phe-Pro
-Asn-Ser. Although trypsin fully activates the zymogen, the activation
rate by plasmin or leukocyte elastase is confined to similar to 50%.
ProMMP-7 can be activated by MMP-3 (stromelysin 1) to its full activit
y in a single-step mechanism and generates the same NH2 terminus obtai
ned by APMA activation, whereas MMP-1 (tissue collagenase), MMP-2 (gel
atinase A), and MMP-9 (gelatinase B) do not have such an effect, On th
e other hand, proMMP-1 is activated by MMP-7 to an activity similar to
that obtained by APMA and the activation by MMP-7 is enhanced up to s
imilar to 6.5 fold in the presence of APMA, This enhanced activity is
donated by specific cleavage at the Gln(80)-Phe(81) bond of proMMP-1.
MMP-7 can also activate proMMP-9 up to similar to 50% of the full acti
vity with a new NH2 terminus of Leu(16)-Arg-Thr-(Asn)-Leu. Incubation
of proMMP-2 or proMMP-3 with MMP-7 results in no activation of these p
roMMPs. MMP-7 degrades type IV collagen, laminin-1, fibronectin, prote
oglycan, type I gelatin, and insoluble elastin, These results suggest
that in vivo MMP-7 may play a role in degradation of extracellular mat
rix macromolecules in concert with MMP-1, -3, and -9 under pathologica
l conditions.